Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

GRIFOLS DIAGNOSTIC

Bioscience division carries out all activities relating to plasma products for therapeutic use, including research, d... read more Featured Products: More products

Download Mobile App




Fully Automated Hepatitis E Virus Assay Now CE-marked

By LabMedica International staff writers
Posted on 06 Aug 2014
Clinical laboratories in Europe now have available a fully automated and highly sensitive NAT (nucleic acid technology) test with CE-marking for the detection of Hepatitis E virus (HEV) RNA in donors of blood, blood components, tissues, and organs.

The Procleix HEV assay is produced by Grifols Diagnostic Solutions Inc. More...
(Barcelona, Spain) and was designed for use on the fully automated Procleix Panther analytical system, which is manufactured by Hologic Inc. (Bedford, MA, USA) and distributed by Grifols.

The assay employs nucleic acid amplification to detect all four genotypes of the hepatitis E virus in plasma and serum specimens from human donors, tested individually or in pools. It is also intended for use in testing plasma and serum to screen organ and tissue donors, including cadaveric (non-heart-beating) donors.

The assay will be sold in the European Union for use on the Procleix Panther system, which performs nucleic acid extraction, amplification, and detection all in a single tube. The Procleix Panther system, which was launched in 2012, features built-in process controls for sample and results integrity, and boasts full sample traceability with positive sample ID tracking and RFID tagged fluids. The instrumentation provides precise pipetting with liquid level sensors and dispensers that facilitate consistency and accuracy of system results.

“As the leading provider of NAT solutions to support safe transfusions and efficient, high-quality testing, we are proud to have accelerated development of this test—already scheduled for use in Japan—to meet the needs of the blood community,” said Carsten Schroeder, president of Grifols Diagnostic Solutions Incorporated.

Related Links:

Grifols Diagnostic Solutions Inc.
Hologic, Inc.



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.